Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Indatuximab ravtansine
Trade Name
Synonyms BT062
Drug Descriptions

Indatuximab Ravtansine (BT062) is an antibody-drug conjugate (ADC) comprising an antibody that targets CD138 linked to the cytotoxic drug DM4, which potentially inhibits growth of CD138-expressing tumors (PMID: 29666962).

DrugClasses

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Docetaxel + Indatuximab ravtansine Docetaxel Indatuximab ravtansine 0 0
Indatuximab ravtansine Indatuximab ravtansine 0 0
Indatuximab ravtansine + Paclitaxel Indatuximab ravtansine Paclitaxel 0 0


Additional content available in CKB BOOST